Is needle electromyography safe in patients on anticoagulation or antiplatelet therapy?

Nature Clinical Practice Neurology

Volumn 5, Issue 2, 2009, Pages 78-79

  Patwa, Huned S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; WARFARIN;

ANTICOAGULANT THERAPY; ELECTROMYOGRAPHY; HUMAN; INTERNATIONAL NORMALIZED RATIO; MUSCLE ATROPHY; MUSCLE BLEEDING; MUSCLE HEMATOMA; NEUROPHYSIOLOGICAL RECRUITMENT; NOTE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TIBIALIS ANTERIOR MUSCLE;

EID: 59849089419     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro1005     Document Type: Note

References (7)

1. Al-Shekhlee A et al. (2003) latrogenic complications and risks of nerve conduction studies and needle electromyography. Muscle Nerve 27: 517-526
2. Farrell CM et al. (2003) Acute compartment syndrome of the leg following diagnostic electromyography. Muscle Nerve 27: 374-377
3. Vaienti L et al. (2005) Compartment syndrome of the forearm following an electromyographic assessment. J Hand Surg [Br] 30 656-657
4. Gruis KL et al. (2006) Survey of electrodiagnostic laboratories regarding hemorrhagic complications from needle electromyography. Muscle Nerve 34: 356-358
5. American Association of Electrodiagnostic Medicine (1999) Guidelines in electrodiagnostic medicine: Risks in electrodiagnostic medicine. Muscle Nerve 8 (Suppl): S53-S69
6. Caress JB et al. (1996) Paraspinal muscle hematoma after electromyography. Neurology 47: 269-272
7. Lynch SL et al. (2008) Complications of needle electromyography: hematoma risk and correlation with anticoagulation and antiplatelet therapy. Muscle Nerve 38: 1225-1230